SCHEMBL14285044

SCHEMBL14285044

C[C@]12CCC(=O)C=C1CCC1C2[C@H](O)C[C@@]2(C)C1CC[C@@]21CCC(=O)O1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 9/20 0.66
▸ LMNA P02545 4/20 0.66
▸ NR3C2 P08235 5/20 0.62
▸ SMN1; SMN2 Q16637 4/20 0.62
▸ NR3C1 P04150 3/20 0.62
▸ PGR P06401 3/20 0.62
▸ CYP2C19 P33261 2/20 0.62
▸ HSD17B10 Q99714 2/20 0.62
▸ SERPINA6 P08185 2/20 0.62
▸ CYP3A4 P08684 2/20 0.62
▸ KMT2A Q03164 2/20 0.62
▸ MAPT P10636 2/20 0.62
▸ SHBG P04278 1/20 0.62
▸ NFKB1 P19838 1/20 0.62
▸ AR P10275 1/20 0.58
▸ CHRM1 P11229 1/20 0.58
▸ HSD11B1 P28845 2/20 0.56
▸ HSD11B2 P80365 2/20 0.56
▸ BLM P54132 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14568530 1.00 HIF1A (0.66) HIF1ALMNANR3C2SMN1; SMN2NR3C1
SCHEMBL8241662 0.86 HIF1A (0.63) HIF1ALMNANR3C2SMN1; SMN2NR3C1
SCHEMBL14308729 0.85 HIF1A (0.54) HIF1ALMNANR3C2SMN1; SMN2NR3C1
Spriolactone SCHEMBL8259555 0.84 SHBG (0.67) HIF1ALMNANR3C2SMN1; SMN2NR3C1
Spriolactone SCHEMBL10786113 0.84 SHBG (0.67) HIF1ALMNANR3C2SMN1; SMN2NR3C1
Spriolactone SCHEMBL18218188 0.84 SHBG (0.67) HIF1ALMNANR3C2SMN1; SMN2NR3C1
Spriolactone SCHEMBL20459223 0.84 SHBG (0.67) HIF1ALMNANR3C2SMN1; SMN2NR3C1
Spriolactone SCHEMBL14285054 0.84 SHBG (0.67) HIF1ALMNANR3C2SMN1; SMN2NR3C1
Spriolactone SCHEMBL8260326 0.84 SHBG (0.67) HIF1ALMNANR3C2SMN1; SMN2NR3C1
Spriolactone SCHEMBL30112125 0.84 SHBG (0.67) HIF1ALMNANR3C2SMN1; SMN2NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080027237-A1 Processes for preparations of 9,11-epoxy steroids and intermediates useful therein NG JOHN S 2008-01-31 — — US disclosed
US-20080027237-A1 Processes for preparations of 9,11-epoxy steroids and intermediates useful therein NG JOHN S 2008-01-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027237-A1 Processes for preparations of 9,11-epoxy steroids and intermediates useful therein CYP4A11, CYP11B1, CYP17A1 HIF1A 2302/4885LMNA 1449/4885NR3C2 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback